.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Express Scripts
McKinsey
US Department of Justice
Covington
Farmers Insurance
Queensland Health
Medtronic
Johnson and Johnson
UBS

Generated: November 21, 2017

DrugPatentWatch Database Preview

FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE Drug Profile

« Back to Dashboard

Which patents cover Fosinopril Sodium And Hydrochlorothiazide, and what generic Fosinopril Sodium And Hydrochlorothiazide alternatives are available?

Fosinopril Sodium And Hydrochlorothiazide is a drug marketed by Mylan, Actavis Labs Fl Inc, Emcure Pharms India, Invagen Pharms, Sun Pharm Inds Ltd, Watson Labs, Aurobindo Pharma, Teva, and Sandoz. and is included in nine NDAs.

The generic ingredient in FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE is fosinopril sodium; hydrochlorothiazide. There are six drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the fosinopril sodium; hydrochlorothiazide profile page.

Summary for FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE

Pharmacology for FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan
FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE
fosinopril sodium; hydrochlorothiazide
TABLET;ORAL077705-001Aug 14, 2006DISCNNoNo► Subscribe► Subscribe► Subscribe
Sandoz
FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE
fosinopril sodium; hydrochlorothiazide
TABLET;ORAL076961-002Sep 28, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe
Invagen Pharms
FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE
fosinopril sodium; hydrochlorothiazide
TABLET;ORAL090228-001Jul 9, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl Inc
FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE
fosinopril sodium; hydrochlorothiazide
TABLET;ORAL076608-002Dec 3, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE
fosinopril sodium; hydrochlorothiazide
TABLET;ORAL077144-002Aug 16, 2005DISCNNoNo► Subscribe► Subscribe► Subscribe
Invagen Pharms
FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE
fosinopril sodium; hydrochlorothiazide
TABLET;ORAL090228-002Jul 9, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Teva
FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE
fosinopril sodium; hydrochlorothiazide
TABLET;ORAL076945-002Jul 5, 2006DISCNNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma
FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE
fosinopril sodium; hydrochlorothiazide
TABLET;ORAL079245-002Jul 9, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan
FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE
fosinopril sodium; hydrochlorothiazide
TABLET;ORAL077705-002Aug 14, 2006DISCNNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl Inc
FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE
fosinopril sodium; hydrochlorothiazide
TABLET;ORAL076608-001Dec 3, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
Fuji
Cantor Fitzgerald
Daiichi Sankyo
Queensland Health
Novartis
Julphar
Chinese Patent Office
Colorcon
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot